Leishmaniasia: gaixotasun globala. Tratamendurako hautagai berriak

Authors

  • Itziar De Miguel University of Navarra
  • Aroia Burguete-Mikeo Nafarroako Unibertsitatea, ISTUN Osasun Tropikaleko Institutua, Mikrobiologia eta parasitologia saila, IdiSNA
  • Rima El Dirany University of Navarra
  • José Peña University of Navarra
  • Celia Fernández University of Navarra
  • Paul Nguewa University of Navarra

DOI:

https://doi.org/10.26876/ikergazte.v.05.17

Keywords:

leishmaniasis, treatments, macrophages, amastigotes, promastigotes, Navarre

Abstract

Leishmaniasis is spreading in Europe and the main treatments available exhibit several disadvantages. This paper aims to address these two aspects. Leishmania infantum parasites have been isolated and identified from a lymph node sample obtained from a dog with leishmaniasis in Navarra. The leishmanicidal activity of the compounds R38 and R38-P has been studied. Compound R38 is a promising drug against leishmaniasis due to its ability to reduce the percentage of infected macrophages.

License

Copyright (c) 2023 IkerGazte. Nazioarteko ikerketa euskaraz

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Downloads

Published

2023-05-09

How to Cite

De Miguel, I., Burguete-Mikeo, A., El Dirany, R., Peña, J., Fernández, C., & Nguewa, P. (2023). Leishmaniasia: gaixotasun globala. Tratamendurako hautagai berriak. IkerGazte. Nazioarteko Ikerketa Euskaraz, 5, 137–144. https://doi.org/10.26876/ikergazte.v.05.17

Conference Proceedings Volume

Vol. 5 (2023): V. Ikergazte. Nazioarteko ikerketa euskaraz. Kongresuko artikulu bilduma. Zientziak eta Natura Zientziak

Section

Artikuluak

Categories